摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[[(1,1-二甲基乙氧基)羰基]氨基]-5-甲氧基苯甲酸 | 262614-64-2

中文名称
2-[[(1,1-二甲基乙氧基)羰基]氨基]-5-甲氧基苯甲酸
中文别名
2-N-Boc-氨基-5-甲氧基苯甲酸;2-N-BOC-氨基-5-甲氧基苯甲酸
英文名称
2-(tert-butoxycarbonylamino)-5-methoxybenzoic acid
英文别名
2-N-Boc-Amino-5-methoxybenzoic acid;5-methoxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]benzoic acid
2-[[(1,1-二甲基乙氧基)羰基]氨基]-5-甲氧基苯甲酸化学式
CAS
262614-64-2
化学式
C13H17NO5
mdl
——
分子量
267.282
InChiKey
JBXGOBGRVPAQEQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    366.7±32.0 °C(Predicted)
  • 密度:
    1.243±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    19
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    84.9
  • 氢给体数:
    2
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2924299090

SDS

SDS:a2b8d1e8c42b816314ed970ed8b6a892
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-[[(1,1-二甲基乙氧基)羰基]氨基]-5-甲氧基苯甲酸4-二甲氨基吡啶1,1-二氯甲醚 作用下, 以 二氯甲烷氯仿 为溶剂, 反应 27.0h, 生成 (S)-4-(2-(2-amino-5-methoxybenzoyloxy)-2-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)ethyl)-3,5-dichloropyridine 1-oxide
    参考文献:
    名称:
    Novel Class of Benzoic Acid Ester Derivatives as Potent PDE4 Inhibitors for Inhaled Administration in the Treatment of Respiratory Diseases
    摘要:
    The first steps in the selection process of a new anti-inflammatory drug for the inhaled treatment of asthma and chronic obstructive pulmonary disease are herein described. A series of novel ester derivatives of 1-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)-2-(3,5-di-chloropyriclin-4-yl) ethanol have been synthesized and evaluated for inhibitory activity toward cAMP-specific phosphodiesterase-4 (PDE4). In particular, esters of variously substituted benzoic acids were extensively explored, and structural modification of the alcoholic and benzoic moieties were performed to maximize the inhibitory potency. Several compounds with high activity in cell-free and cell-based assays were obtained. Through the evaluation of opportune in vitro ADME properties, a potential candidate suitable for inhaled administration in respiratory diseases was identified and tested in an in vivo model of pulmonary inflammation, proving its efficacy.
    DOI:
    10.1021/jm401549m
  • 作为产物:
    描述:
    二碳酸二叔丁酯2-氨基-5-甲氧基苯甲酸吡啶 作用下, 反应 2.5h, 以78%的产率得到2-[[(1,1-二甲基乙氧基)羰基]氨基]-5-甲氧基苯甲酸
    参考文献:
    名称:
    通过基于片段的筛选发现首个结核分枝杆菌MabA(FabG1)抑制剂。
    摘要:
    结核分枝杆菌(M.tb)是结核病的病原体,仍然是全球单一传染病致死的主要原因。耐药性结核分枝杆菌的出现菌株强调需要药物作用于新靶标。分枝杆菌酸是很长的链脂肪酸,在分枝杆菌细胞壁的结构和渗透性中起着至关重要的作用。它们的生物合成涉及两个脂肪酸合酶(FAS)系统。在FAS-II周期的四种酶(MabA,HadAB / BC,InhA和KasA / B)中,MabA(FabG1)仍然是唯一尚未报道特异性抑制剂的酶。新的基于LC-MS / MS的酶促测定方法的开发,可以筛选1280个片段文库,并导致发现了第一个抑制MabA活性的小分子。将邻氨基苯甲酸系列的片段优化为更有效的抑制剂,并通过19 F配体观察的NMR实验证实了它们与MabA的结合。
    DOI:
    10.1016/j.ejmech.2020.112440
点击查看最新优质反应信息

文献信息

  • Escaping from Flatland: Antimalarial Activity of sp<sup>3</sup>-Rich Bridged Pyrrolidine Derivatives
    作者:Brian Cox、James Duffy、Victor Zdorichenko、Corentin Bellanger、Jessica Hurcum、Benoît Laleu、Kevin I. Booker-Milburn、Luke D. Elliott、Michael Robertson-Ralph、Christopher J. Swain、Stephen J. Bishop、Irene Hallyburton、Mark Anderson
    DOI:10.1021/acsmedchemlett.0c00486
    日期:2020.12.10
    We utilized synthetic photochemistry to generate novel sp3-rich scaffolds and report the design, synthesis, and biological testing of a diverse series of amides based on the 1-(amino-methyl)-2-benzyl-2-aza-bicyclo[2.1.1]hexane scaffold. Preliminary antimalarial screening of the library provided promising compounds with activity in the 1–5 μM range with an enhanced hit rate. Further evaluation (solubility
    我们利用合成光化学生成了新型富含sp 3 的支架,并报告了基于 1-(氨基-甲基)-2-苄基-2-氮杂-双环 [2.1 .1]己烷支架。该文库的初步抗疟筛选提供了有希望的化合物,其活性范围为 1–5 μM,并具有更高的命中率。所选化合物 ( 9 ) 的进一步评估(溶解度、药物代谢和药代动力学 (DMPK) 和毒性)表明,该系列代表了进一步优化的绝佳机会,该框架为添加独特的矢量定位的额外功能提供了多种机会。
  • Two-step syntheses of fused quinoxaline-benzodiazepines and bis-benzodiazepines
    作者:Zhigang Xu、Justin Dietrich、Arthur Y. Shaw、Christopher Hulme
    DOI:10.1016/j.tetlet.2010.06.116
    日期:2010.8
    A two-step solution phase synthesis employing a double UDC (Ugi/Deprotect/Cyclize) strategy has been utilized to obtain fused 6,7,6,6-quinoxalinone-benzodiazepines and 6,7,7,6-bis-benzodiazepines. Optimization of the methodology to produce these tetracyclic scaffolds was enabled by microwave irradiation, incorporation of trifluoroethanol as solvent, and the use of the convertible isocyanide, 4-tert-butyl
    采用双 UDC(Ugi/脱保护/环化)策略的两步液相合成已被用于获得融合的 6,7,6,6-喹喔啉酮-苯二氮卓类和 6,7,7,6-双-苯二氮卓类。通过微波辐射、加入三氟乙醇作为溶剂以及使用可转化的异氰化物 4-叔丁基环己烯-1-基异氰化物来优化生产这些四环支架的方法。
  • New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
    申请人:Auvin Serge
    公开号:US20050261269A1
    公开(公告)日:2005-11-24
    Novel derivatives of amidines of formula wherein the substituents are defined as in the specification which are useful for inhibiting activity on NO-synthase enzymes producing nitrogen mono oxide and/or trapping the reactive oxygen species (ROS) making them useful for treating various diseases.
    该项发明涉及公式中所定义的取代基的新型氨基甲酸酰胺衍生物,其对产生一氧化氮的NO合酶酶活性具有抑制作用,并且对于捕获反应性氧化物种(ROS)也具有作用,因此对于治疗各种疾病是有用的。
  • Synthesis of a quinolone library from ynones
    作者:Timothy R. Ward、Brandon J. Turunen、Torsten Haack、Benjamin Neuenswander、William Shadrick、Gunda I. Georg
    DOI:10.1016/j.tetlet.2009.09.024
    日期:2009.11
    A library of 72 quinolones was synthesized from substituted anthranilic acids, using ynone intermediates. These masked beta-dicarbonyl synthons allowed cyclization under milder conditions than previously reported quinolone syntheses. (C) 2009 Elsevier Ltd. All rights reserved
  • An efficient solution phase synthesis of triazadibenzoazulenones: ‘designer isonitrile free’ methodology enabled by microwaves
    作者:Christopher Hulme、Shashi Chappeta、Chris Griffith、Yeon-Sun Lee、Justin Dietrich
    DOI:10.1016/j.tetlet.2009.02.099
    日期:2009.4
    A novel two-step solution phase protocol for the synthesis of arrays of triazadibenzoazulenones is reported. The methodology employs the Ugi reaction to assemble desired diversity and acid treatment enables two tandem ring closing transformations. The order of ring closure is shown to be key for optimal conversion to the desired tetra-cyclic product and initially proceeds through a benzimidazole intermediate, followed by second ring closure to give the desired fused benzodiazepine. The two-step protocol is further facilitated by microwave irradiation. Prudent selection of the isonitrile reagent enables the correct order of ring forming events. As such the methodology represents the first example of a post-condensation Ugi modification that employs two internal amino nucleophiles. (C) 2009 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐